![Marc Yoskowitz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc Yoskowitz
Direttore/Membro del Consiglio presso MEREO BIOPHARMA GROUP PLC
Patrimonio netto: - $ in data 30/06/2024
Provenienza dei contatti di primo grado di Marc Yoskowitz
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 22 | |
Tempus Labs, Inc.
![]() Tempus Labs, Inc. Packaged SoftwareTechnology Services Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.
9
| Public Company | Packaged Software | 9 |
Evozyne Inc
![]() Evozyne Inc Miscellaneous Commercial ServicesCommercial Services Evozyne provides data-driven molecular engineering services. The company is headquartered in Chicago, IL.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Marc Yoskowitz tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Scios, Inc.
![]() Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member President Corporate Officer/Principal | |
Phase4 Partners Ltd.
![]() Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Investment Committee Member Chief Executive Officer Director/Board Member | |
ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Director/Board Member | |
Cocoon Biotech, Inc.
![]() Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
The Boston Consulting Group, Inc.
![]() The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Indiana University | College/University | Doctorate Degree | |
British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal | |
The University of Colorado | College/University | Doctorate Degree | |
London School of Hygiene & Tropical Medicine | College/University | Corporate Officer/Principal | |
US Food & Drug Administration
![]() US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree Director/Board Member | |
National Academy of Medicine (United States)
![]() National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
CellMedical SA
![]() CellMedical SA Medical/Nursing ServicesHealth Services CellMedical SA operates medical diagnostic laboratories. The company is headquartered in Thessaloniki, Greece. | Medical/Nursing Services | Chairman | |
The European Commission | General Government | Corporate Officer/Principal | |
Albireo Ltd.
![]() Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kuur Therapeutics Ltd.
![]() Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Albireo AB
![]() Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Oncimmune Ltd.
![]() Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Director/Board Member | |
PlaqueTec Ltd.
![]() PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Tizona Therapeutics, Inc.
![]() Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer | |
ONCIMMUNE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Mereo Biopharma 3 Ltd.
![]() Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Part of Mereo BioPharma Group Plc, Mereo Biopharma 3 Ltd. develops bio pharm products. The company is based in London, UK. | Biotechnology | Director/Board Member Director/Board Member | |
Mereo BioPharma 2 Ltd.
![]() Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 2 Ltd. is a British company that provides research and experimental development for biotechnology. The company is based in London, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Thrombolytic Science International LLC
![]() Thrombolytic Science International LLC Pharmaceuticals: MajorHealth Technology Thrombolytic Science International LLC operates as a vascular medicine and biotech company. The company was founded by Alexis Wallace and Victor Gurewich and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Mereo BioPharma 4 Ltd.
![]() Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 4 Ltd. is a British biotechnology company founded in 2017 that provides research and development services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
COMPASS Pathfinder Holdings Ltd.
![]() COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017. | Financial Conglomerates | Director/Board Member | |
PhESi LLC
![]() PhESi LLC Pharmaceuticals: MajorHealth Technology PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme. | Pharmaceuticals: Major | Director/Board Member | |
AOBiome Therapeutics, Inc.
![]() AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
Phaim Pharma Ltd. | Director/Board Member | ||
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 29 |
Regno Unito | 18 |
Paesi Bassi | 2 |
Grecia | 2 |
Lussemburgo | 2 |
Settori
Health Technology | 28 |
Commercial Services | 9 |
Consumer Services | 8 |
Finance | 3 |
Health Services | 3 |
Posizioni
Director/Board Member | 258 |
Corporate Officer/Principal | 101 |
Independent Dir/Board Member | 75 |
Chairman | 47 |
Founder | 32 |
Contatti più connessi
Insiders | |
---|---|
Annalisa Jenkins | 51 |
Jeffrey Aronin | 35 |
Deepa Pakianathan | 32 |
Michael Wyzga | 31 |
Anders Olof Adolf Ekblom | 27 |
Scott Gottlieb | 26 |
Jennifer Doudna | 26 |
John P. Richard | 24 |
Wayne Frederick | 24 |
Peter John Fellner | 21 |
Denise Scots-Knight | 20 |
Joel Dudley | 20 |
Michael Gamson | 15 |
Nadja West | 13 |
Robert Ghenchev | 13 |
- Borsa valori
- Insiders
- Marc Yoskowitz
- Connessioni Società